These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6419558)

  • 21. The risk of arachnoiditis from experimental nonionic contrast media.
    Haughton VM; Ho KC
    Radiology; 1980 Aug; 136(2):395-7. PubMed ID: 6773100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iopamidol for myelography. A clinical trial with a new non-ionic contrast medium.
    Peeters F; van Dongen K; Hekster R; Hoogland P; Thijssen H; Tjian T; Wilmink J; Althuisius H
    Diagn Imaging; 1983; 52(6):313-5. PubMed ID: 6357678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonionic dimer: development and initial testing of an intrathecal contrast agent.
    Sovak M; Ranganathan R; Speck U
    Radiology; 1982 Jan; 142(1):115-8. PubMed ID: 6895557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast enhancement pharmacokinetics of six ionic and nonionic contrast media.
    Dean PB; Kivisaari L; Kormano M
    Invest Radiol; 1983; 18(4):368-74. PubMed ID: 6618828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Side effects of 2 water-soluble contrast media used in myelography].
    Caillé JM
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):779-82. PubMed ID: 6689467
    [No Abstract]   [Full Text] [Related]  

  • 26. Brain penetration of intrathecal iomeprol in dogs.
    La Noce A; Lorenzon P; Pugliese F; Pellecchi G; Orlandini I; Tirone P
    Acta Radiol; 1996 Jul; 37(4):578-81. PubMed ID: 8688246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects induced by the injection of a new nonionic contrast medium (Iopamidol): experimental study in dogs.
    Di Donato M; Bongrani S; Cucchini F; Baldi G; Fappani A; Colla B; Visioli O
    Invest Radiol; 1979; 14(4):309-15. PubMed ID: 489271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iopamidol vs. metrizamide myelography: clinical comparison of side effects.
    Trevisan C; Malaguti C; Manfredini M; Tampieri D
    AJNR Am J Neuroradiol; 1983; 4(3):306-8. PubMed ID: 6410728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotoxicologic effects of the nonionic contrast agent iopamidol on the leptomeninges of the dog.
    Spencer CP; Chrisman CL; Mayhew IG; Kaude JV
    Am J Vet Res; 1982 Nov; 43(11):1958-62. PubMed ID: 6891192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative neurotoxicity of angiographic contrast media.
    Velaj R; Drayer B; Albright R; Fram E
    Neurology; 1985 Sep; 35(9):1290-8. PubMed ID: 3927186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iotrol, a new water-soluble non-ionic dimeric contrast medium for intrathecal use.
    Hammer B; Deisenhammer E
    Neuroradiology; 1985; 27(4):337-41. PubMed ID: 3900800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacology of nonionic roentgen contrast media].
    Turnheim K
    Wien Klin Wochenschr; 1986 May; 98(11):333-8. PubMed ID: 3727593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intrathecal roentgen contrasting--experiences with iopamidol].
    Stellamor V; Stellamor K; Perneczky G
    Rontgenpraxis; 1984 Jun; 37(6):213-9. PubMed ID: 6548320
    [No Abstract]   [Full Text] [Related]  

  • 34. Iohexol and iopamidol: second-generation nonionic radiographic contrast media.
    Kawada TK
    Drug Intell Clin Pharm; 1985; 19(7-8):525-9. PubMed ID: 3896713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of various contrast agents for improved arthrography.
    Katzberg RW; Burgener FA; Fischer HW
    Invest Radiol; 1976; 11(6):528-33. PubMed ID: 1002406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An assessment of iopamidol, a non-ionic contrast medium, in aorto-femoral angiography.
    Whitehouse GH; Snowdon SL
    Clin Radiol; 1982 Mar; 33(2):231-4. PubMed ID: 7067356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myelography with iopamidol, a nonionic water-soluble contrast medium: incidence of complications.
    Bassi P; Cecchini A; Dettori P; Signorini E
    Neuroradiology; 1982; 24(2):85-90. PubMed ID: 7177375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arachnoiditis from myelography with iopamidol, metrizamide, and iocarmate compared in the animal model.
    Haughton VM; Ho KC
    Invest Radiol; 1980; 15(6 Suppl):S267. PubMed ID: 7203934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotoxicity of nonionic iodinated water-soluble contrast media in myelography: experimental study.
    Caillé JM; Gioux M; Arné P; Paty J
    AJNR Am J Neuroradiol; 1983; 4(6):1185-9. PubMed ID: 6419559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [1st experience with Solutrast, a new contrast medium for myelography].
    Thun F
    Rontgenblatter; 1983 Jan; 36(1):6-9. PubMed ID: 6823535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.